Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/18/2811263/0/en/Orphalan-announces-China-NMPA-s-approval-of-its-trientine-tetrahydrochloride-product-for-the-treatment-of-Wilson-disease.html
https://www.globenewswire.com/news-release/2023/04/20/2650813/0/en/Orphalan-announces-US-commercial-launch-of-Cuvrior-for-the-treatment-of-Wilson-disease.html
https://www.globenewswire.com/news-release/2022/09/30/2525726/0/en/Orphalan-announces-publication-of-results-from-the-CHELATE-trial-in-The-Lancet-Gastroenterology-Hepatology.html
https://www.globenewswire.com/news-release/2022/07/26/2485543/0/en/Orphalan-announces-enrolment-of-the-first-five-patients-in-the-International-Wilson-s-Disease-Patient-Registry-iWD-Registry.html
https://www.globenewswire.com/news-release/2022/06/22/2466773/0/en/Orphalan-announces-data-from-secondary-analyses-of-the-CHELATE-trial-for-maintenance-patients-with-Wilson-s-Disease.html